![INFARMED NÃO APROVA MEDICAMENTO PARA CANCRO DA MAMA || Análise à Comissão [Pembrolizumab] // Podcast episode artwork](https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_episode/4642460/4642460-1686955686066-3c9d8b786826d.jpg)
EPISODE · Jun 16, 2023 · 1H 16M
INFARMED NÃO APROVA MEDICAMENTO PARA CANCRO DA MAMA || Análise à Comissão [Pembrolizumab] // Podcast
from Miguel Macedo Podcast · host Miguel Macedo
Uma audição que passou em branco por toda comunicação social, mas que é de extrema importância. Para entender melhor, assista a esta live no canal.
Embed this episode
NOW PLAYING
INFARMED NÃO APROVA MEDICAMENTO PARA CANCRO DA MAMA || Análise à Comissão [Pembrolizumab] // Podcast
0:00
1:16:49
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Miguel Macedo Podcast?
This episode is 1 hour and 16 minutes long.
When was this Miguel Macedo Podcast episode published?
This episode was published on June 16, 2023.
Can I download this Miguel Macedo Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!